GlassScriptPhysician profile
Jamie E Gottlieb
NPI 1811979842
$15,145.58
in general payments reported to CMS, 2019-2025
29 companies · $655 in 2025
The $655 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.89 · 2020: $315 · 2021: $2,229 · 2022: $2,333 · 2023: $8,753 · 2024: $765 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,290 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,120 · Food and Beverage: $2,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,290.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,120.00 |
| Food and Beverage | $2,762.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $10,426.56 | 2020-2024 | Senza |
| Abbott Laboratories | $1,442.10 | 2021-2025 | Proclaim, Eterna |
| Mml US, INC. | $1,113.25 | 2021 | |
| Amplify Surgical, INC. | $331.84 | 2022-2023 | Dualx and Dualportal |
| Seaspine Orthopedics Corporation | $301.01 | 2019-2021 | |
| Globus Medical, INC. | $274.83 | 2025 | Senza |
| Integrity Implants INC. Dba Accelus | $165.21 | 2024 | |
| Si-Bone, INC. | $142.19 | 2022-2025 | |
| Medtronic USA, INC. | $136.17 | 2020 | |
| Intrinsic Therapeutics | $96.36 | 2023 | Barricaid Acd (Annular Closure Device) |
| Saluda Medical Americas, INC. | $80.00 | 2025 | Evoke |
| Alevio, LLC | $69.00 | 2022 | |
| Genesys Orthopedics Systems, L.L.C. | $66.00 | 2023 | Binary |
| Nalu Medical, INC. | $62.65 | 2022-2025 | Nalu Neurostimulation System |
| Medtronic, INC. | $51.77 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Core Surgical Group | $51.18 | 2023 | |
| Boston Scientific Corporation | $50.74 | 2020-2025 | Intracept |
| Intuitive Surgical, INC. | $44.19 | 2022 | |
| Integra Lifesciences Corporation | $38.78 | 2022 | |
| Biotissue Holdings INC. | $33.72 | 2023 | |
| Orthofix Medical, INC. | $27.86 | 2024-2025 | Spinal-Stim |
| Pylant Medical | $23.49 | 2025 | |
| Spinal Simplicity, LLC | $21.69 | 2024 | Ha Minuteman G3-R |
| Baxter Healthcare | $20.19 | 2021 | |
| Zyla Life Sciences, INC. | $18.25 | 2020 | |
| Theragen, INC. | $15.00 | 2022 | |
| Sanara Medtech INC. | $14.78 | 2021 | |
| Biotronik Nro, INC. | $13.50 | 2024 | Prospera |
| Amgen INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Gottlieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.